Stock BSFA BSF ENTERPRISE PLC
Add to a list
To use this feature you must be a member
Log inSign up

Company BSF Enterprise Plc

Equities

BSFA

GB00BHNBDQ51

Pharmaceuticals

Delayed London S.E.
Other stock markets
 06:35:09 2024-05-01 am EDT 		5-day change 1st Jan Change
4.655 GBX -6.90% Intraday chart for BSF Enterprise Plc -6.90% -54.59%
Apr. 12 BSF Enterprise Plc announced that it has received £0.09 million in funding CI
Apr. 11 BSF Enterprise Gets Funding for Development of Cultivated Leather MT

Business Summary

BSF Enterprise PLC is a United Kingdom-based biotechnology company. The Company is focused on developing biotechnological solutions using cell-based tissue engineering to help generate cultured meat, lab-grown leather, as well as human corneas, collagen growth and skin substitutes. The Company operates through its wholly owned subsidiary, 3D Bio-Tissues Limited (3DBT), which is a clinical and cellular agriculture company engaged in producing human corneas that could help restore vision to millions of people. 3DBT has three strands of three intellectual property (IP) each with a different sector focus development and revenue timeline. 3DBT’s City-mix is an animal-free cell growth agent for culturing skin, muscle and fat cells which are used for lab-grown meat and leather production. 3DBT’s Lipopeptide Etsyl actively increases collagen production in human skin cells which can be used in cosmetic and skin care products.

Number of employees: 12

Sales per Business

GBP in Million2022Weight2023Weight Delta
Research
88.2 %
- - 0 88.2 % -
Consumable
11.8 %
- - 0 11.8 % -

Sales per region

GBP in Million2022Weight2023Weight Delta
United Kingdom
100.0 %
0 nan % 0 100.0 % -

Managers

Managers TitleAgeSince
Geoffrey Baker FOU
 Founder 67 18-09-04
Che Connon CEO
 Chief Executive Officer 52 -
Graham Duncan DFI
 Director of Finance/CFO 61 22-06-05

Members of the board

Members of the board TitleAgeSince
Min Yang FOU
 Founder 56 18-09-04
Geoffrey Baker FOU
 Founder 67 18-09-04
Kian Jing Ow BRD
 Director/Board Member 58 21-08-04
Che Connon CEO
 Chief Executive Officer 52 -

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 103,336,937 46,891,238 ( 45.38 %) 0 45.38 %

Shareholders

NameEquities%Valuation
Bsf Angel Funding Ltd.
16.07 %
16,610,944 16.07 % 1 M p
Che Connon
12.51 %
12,927,977 12.51 % 963 522 p
Newcastle University
6.692 %
6,915,624 6.692 % 515 421 p
Kian Jing Ow
5.593 %
5,779,850 5.593 % 430 772 p
Myles Mcnulty
2.947 %
3,045,000 2.947 % 226 944 p
Geoffrey Baker
1.509 %
1,559,699 1.509 % 116 244 p
Advance Plan Investments Ltd.
0.004839 %
5,000 0.004839 % 373 p

Company contact information

BSF Enterprise Plc

31 Old Burlington Street Ground Floor

W1S 3AS, London

+

http://www.bsfenterprise.com
address BSF Enterprise Plc(BSFA)

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Biopharmaceuticals

Sales per Business

Sector Biopharmaceuticals

1st Jan change Capi.
BSF ENTERPRISE PLC Stock BSF Enterprise Plc
-54.59% 6.47M
CSL LIMITED Stock CSL Limited
-4.24% 86.85B
SAMSUNG BIOLOGICS CO.,LTD. Stock Samsung Biologics Co.,Ltd.
+2.76% 40.16B
BIOGEN INC. Stock Biogen Inc.
-16.98% 31.28B
UCB Stock UCB
+57.86% 25.27B
BIOMARIN PHARMACEUTICAL INC. Stock BioMarin Pharmaceutical Inc.
-16.24% 15.33B
BEIJING WANTAI BIOLOGICAL PHARMACY ENTERPRISE CO., LTD. Stock Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.
-9.12% 11.96B
CHONGQING ZHIFEI BIOLOGICAL PRODUCTS CO., LTD. Stock Chongqing Zhifei Biological Products Co., Ltd.
-42.56% 11.61B
INCYTE CORPORATION Stock Incyte Corporation
-17.10% 11.69B
SWEDISH ORPHAN BIOVITRUM AB Stock Swedish Orphan Biovitrum AB
+6.89% 8.83B
Biopharmaceuticals
  1. Stock Market
  2. Equities
  3. BSFA Stock
  4. Company BSF Enterprise Plc